Literature DB >> 31907844

Glutamate-Weighted CEST Contrast After Removal of Magnetization Transfer Effect in Human Brain and Rat Brain with Tumor.

Ayan Debnath1,2, Hari Hariharan2, Ravi Prakash Reddy Nanga2, Ravinder Reddy2, Anup Singh3,4.   

Abstract

PURPOSE: To mitigate the effect of magnetization transfer (MT) from glutamate-weighted chemical exchange saturation transfer (GluCEST) contrast in healthy human brain and its demonstration in a rat brain tumor model. PROCEDURES: GluCEST data was acquired from six healthy human volunteers at 7T and on a rat brain with tumor at 9.4 T. Single voxel proton magnetic resonance spectroscopy (1HMRS) data was acquired from three human volunteers. The magnetic resonance imaging protocol included CEST data acquisition at multiple frequencies for generating Z-spectra, B0 and B1 map. Partial Z-spectra at offset frequencies from ± 100 to ± 14 ppm were fitted to model semi-solid MT component by Lorentzian, Gaussian, super-Lorentzian, and 6th degree polynomial function lineshapes. Average residual errors per pixel was calculated. The MT effect of the Z-spectra was removed by subtracting fitted MT component from Z-spectra. GluCEST was computed as GluCESTNeg (normalized with signal at - 3 ppm) and GluCESTM0 (normalized with unsaturated signal). The difference between GluCEST maps before and after MT removal was compared using T test.
RESULTS: Better accuracy of fitting off-resonance Z-spectra was achieved with super-Lorentzian (σ = 0.0009) and Lorentzian (σ = 0.0017) compared to other lineshapes. There was significant (p < 0.01) increase in GluCESTM0 and decrease in GluCESTNeg contrast after MT removal. GluCESTNeg and GluCESTM0 maps after MT removal using Lorentzian lineshape showed gray matter (GM) to white matter (WM) contrast ratio of 1.47 and 1.52 respectively. These ratios are close to glutamate concentration ratio in GM/WM as observed from 1HMRS data. Thus, the quantity of the MT removed from Z-spectra is appropriate using Lorentzian lineshape due to preservation of GluCEST contrast-ratio in GM/WM. The amount of MT removed from Z-spectra is overestimated using super-Lorentzian and underestimated using Gaussian and polynomial lineshapes. Tumor tissue showed unexpected increase in GluCEST contrast compared to contra-lesional tissue, which represents normal appearing tissue in the brain on contra-lateral side of tumor region, due to decrease in MT component.
CONCLUSIONS: Removal of MT effect from Z-spectra using Lorentzian lineshape increased the specificity of GluCEST contrast to glutamate in healthy human brain and was demonstrated in rat brain tumor model.

Entities:  

Keywords:  Chemical exchange saturation transfer (CEST); GluCEST; Glutamate; Lorentzian; Magnetic resonance imaging (MRI); Magnetization transfer; Super-Lorentzian; Z-spectra

Mesh:

Substances:

Year:  2020        PMID: 31907844     DOI: 10.1007/s11307-019-01465-9

Source DB:  PubMed          Journal:  Mol Imaging Biol        ISSN: 1536-1632            Impact factor:   3.488


  33 in total

Review 1.  Glutamate and glutamine: a review of in vivo MRS in the human brain.

Authors:  Saadallah Ramadan; Alexander Lin; Peter Stanwell
Journal:  NMR Biomed       Date:  2013-10-04       Impact factor: 4.044

2.  On B1 inhomogeneity correction of in vivo human brain glutamate chemical exchange saturation transfer contrast at 7T.

Authors:  Anup Singh; Kejia Cai; Mohammad Haris; Hari Hariharan; Ravinder Reddy
Journal:  Magn Reson Med       Date:  2012-04-17       Impact factor: 4.668

3.  Mapping the alterations in glutamate with GluCEST MRI in a mouse model of dopamine deficiency.

Authors:  Puneet Bagga; Rachelle Crescenzi; Guruprasad Krishnamoorthy; Gaurav Verma; Ravi Prakash Reddy Nanga; Damodar Reddy; Joel Greenberg; John A Detre; Hari Hariharan; Ravinder Reddy
Journal:  J Neurochem       Date:  2016-10-16       Impact factor: 5.372

4.  Imaging of glutamate in the spinal cord using GluCEST.

Authors:  Feliks Kogan; Anup Singh; Catherine Debrosse; Mohammad Haris; Kejia Cai; Ravi Prakash Nanga; Mark Elliott; Hari Hariharan; Ravinder Reddy
Journal:  Neuroimage       Date:  2013-04-09       Impact factor: 6.556

5.  Imaging of glutamate neurotransmitter alterations in Alzheimer's disease.

Authors:  Mohammad Haris; Kavindra Nath; Kejia Cai; Anup Singh; Rachelle Crescenzi; Feliks Kogan; Gaurav Verma; Sanjana Reddy; Hari Hariharan; Elias R Melhem; Ravinder Reddy
Journal:  NMR Biomed       Date:  2012-10-09       Impact factor: 4.044

6.  Reduced hippocampal glutamate in Alzheimer disease.

Authors:  R Rupsingh; M Borrie; M Smith; J L Wells; R Bartha
Journal:  Neurobiol Aging       Date:  2009-06-06       Impact factor: 4.673

7.  In vivo imaging of brain glutamate defects in a knock-in mouse model of Huntington's disease.

Authors:  Jérémy Pépin; Laetitia Francelle; Maria-Angeles Carrillo-de Sauvage; Lucie de Longprez; Pauline Gipchtein; Karine Cambon; Julien Valette; Emmanuel Brouillet; Julien Flament
Journal:  Neuroimage       Date:  2016-06-16       Impact factor: 6.556

8.  Magnetic resonance imaging of glutamate.

Authors:  Kejia Cai; Mohammad Haris; Anup Singh; Feliks Kogan; Joel H Greenberg; Hari Hariharan; John A Detre; Ravinder Reddy
Journal:  Nat Med       Date:  2012-01-22       Impact factor: 53.440

9.  Glutamate imaging (GluCEST) reveals lower brain GluCEST contrast in patients on the psychosis spectrum.

Authors:  D R Roalf; R P R Nanga; P E Rupert; H Hariharan; M Quarmley; M E Calkins; E Dress; K Prabhakaran; M A Elliott; P J Moberg; R C Gur; R E Gur; R Reddy; B I Turetsky
Journal:  Mol Psychiatry       Date:  2017-01-24       Impact factor: 15.992

10.  Elevated glutamatergic compounds in pregenual anterior cingulate in pediatric autism spectrum disorder demonstrated by 1H MRS and 1H MRSI.

Authors:  Anthony Bejjani; Joseph O'Neill; John A Kim; Andrew J Frew; Victor W Yee; Ronald Ly; Christina Kitchen; Noriko Salamon; James T McCracken; Arthur W Toga; Jeffry R Alger; Jennifer G Levitt
Journal:  PLoS One       Date:  2012-07-27       Impact factor: 3.240

View more
  6 in total

1.  Comparisons of Glutamate in the Brains of Alzheimer's Disease Mice Under Chemical Exchange Saturation Transfer Imaging Based on Machine Learning Analysis.

Authors:  Yixuan Liu; Jie Li; Hongfei Ji; Jie Zhuang
Journal:  Front Neurosci       Date:  2022-05-03       Impact factor: 5.152

Review 2.  Hyperpolarized MRI, functional MRI, MR spectroscopy and CEST to provide metabolic information in vivo.

Authors:  Peter C M van Zijl; Kevin Brindle; Hanzhang Lu; Peter B Barker; Richard Edden; Nirbhay Yadav; Linda Knutsson
Journal:  Curr Opin Chem Biol       Date:  2021-07-20       Impact factor: 8.972

3.  Temporal Changes in In Vivo Glutamate Signal during Demyelination and Remyelination in the Corpus Callosum: A Glutamate-Weighted Chemical Exchange Saturation Transfer Imaging Study.

Authors:  Do-Wan Lee; Hwon Heo; Chul-Woong Woo; Dong-Cheol Woo; Jeong-Kon Kim; Kyung-Won Kim; Dong-Hoon Lee
Journal:  Int J Mol Sci       Date:  2020-12-12       Impact factor: 5.923

Review 4.  Molecular Imaging of Brain Tumors and Drug Delivery Using CEST MRI: Promises and Challenges.

Authors:  Jianpan Huang; Zilin Chen; Se-Weon Park; Joseph H C Lai; Kannie W Y Chan
Journal:  Pharmaceutics       Date:  2022-02-20       Impact factor: 6.321

5.  Relaxation-Compensated Chemical Exchange Saturation Transfer MRI in the Brain at 7T: Application in Relapsing-Remitting Multiple Sclerosis.

Authors:  Kristin P O'Grady; Sanjana Satish; Quinn R Owen; Bailey A Box; Francesca Bagnato; Anna J E Combes; Sarah R Cook; Holly James Westervelt; Haley R Feiler; Richard D Lawless; Asha Sarma; Shekinah D Malone; Josephine M Ndolo; Keejin Yoon; Richard D Dortch; Baxter P Rogers; Seth A Smith
Journal:  Front Neurol       Date:  2022-02-25       Impact factor: 4.003

6.  Chemical exchange saturation transfer for detection of antiretroviral drugs in brain tissue.

Authors:  Aditya N Bade; Howard E Gendelman; JoEllyn McMillan; Yutong Liu
Journal:  AIDS       Date:  2021-09-01       Impact factor: 4.632

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.